View Entire Collection
By Clinical Topic
Diabetes – Summer 2012
Future of Nursing Initiative
Heart Failure - Fall 2011
Influenza - Winter 2011
Nursing Ethics - Fall 2011
Trauma - Fall 2010
Traumatic Brain Injury - Fall 2010
Fluids & Electrolytes
TUESDAY, Nov. 27 (HealthDay News) -- Patients who undergo bioprosthetic aortic valve replacement surgery and discontinue anticoagulant treatment within six months have a greater risk of cardiovascular death, according to a study published in the Nov. 28 issue of the Journal of the American Medical Association.
Charlotte Mérie, M.D., from the Copenhagen University Hospital Gentofte in Denmark, and colleagues analyzed outcomes data based on warfarin use from 4,075 patients in Denmark without atrial fibrillation who had bioprosthetic aortic valve replacement surgery from 1997 to 2009.
During a median follow-up of 6.57 person-years, the researchers found that the adjusted incidence rate ratios (IRRs) were higher in patients who did not receive warfarin: 2.46 for stroke, 2.93 for thromboembolic events, and 2.32 for bleeding incidents. In addition, the IRR was 7.61 for cardiovascular deaths when warfarin was discontinued within 30 to 89 days after surgery and 3.51 for cardiovascular deaths when warfarin was discontinued within 90 to 179 days after surgery.
"The novelty of our study is the finding that discontinuing warfarin therapy within 90 to 179 days after surgery is associated with a significant increase in the risk of cardiovascular death," Mérie and colleagues conclude. "Consequently, our study challenges current guidelines on the duration of antithrombotic treatment after aortic valve replacement surgery with biological valves by presenting results suggesting that these patients will gain from an additional three months of warfarin treatment in terms of reduced cardiovascular death without risking a significant increase in bleeding events."
Two authors disclosed financial ties to pharmaceutical companies.
Full Text (subscription or payment may be required)
Editorial (subscription or payment may be required)
Find in-depth content on major issues provided by leading companies in partnership with NursingCenter.com
BD Safety Beyond Needlestick Prevention Learning Center
Sponsored by BD Medical
Sign up for our free enewsletters to stay up-to-date in your area of practice - or take a look at an archive of prior issues
Join our CESaver program to earn up to 100 contact hours for only $34.95
Explore a world of online resources
Back to Top